CD4 and lung carcinoma: The depletion of CD4+ T cells one day before vaccination with SA-4-1BBL admixed with survivin (SVN) as self TAA had no detectable effect on the therapeutic efficacy of the vaccine in the 3LL lung carcinoma model expressing SVN (Fig. 4C).